| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |